Angiotensin-converting enzyme insertion/deletion polymorphism and risk of myocardial infarction in an updated meta-analysis based on 34993 participants

Gene

Volumn 522, Issue 2, 2013, Pages 196-205

  Chen, Yu ^a   Dong, Shiyang ^a   He, Mingfeng ^a   Qi, Tao ^a   Zhu, Wei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin converting enzyme; Etiology; Meta analysis; Myocardial infarction; Polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ALLELE; ARTICLE; ASIAN; CAUCASIAN; ETHNICITY; GENE DELETION; GENE INSERTION; HEART INFARCTION; HUMAN; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ALLELES; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDEL MUTATION; MYOCARDIAL INFARCTION; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK; RISK FACTORS;

EID: 84878105765     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.03.076     Document Type: Article

References (63)

1. Anderson J.L., Carlquist J.F., King G.J., et al. Angiotensin-converting enzyme genotypes and risk for myocardial infarction in women. J. Am. Coll. Cardiol. 1998, 31:790-796.
2. Andrikopoulos G.K., Richter D.J., Needham E.W., et al. The paradoxical association of common polymorphisms of the renin-angiotensin system genes with risk of myocardial infarction. Eur. J. Cardiovasc. Prev. Rehabil. 2004, 11:477-483.
3. Araujo M.A., Goulart L.R., Cordeiro E.R., et al. Genotypic interactions of renin-angiotensin system genes in myocardial infarction. Int. J. Cardiol. 2005, 103:27-32.
4. Arbustini E., Grasso M., Fasani R., et al. Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. Br. Heart J. 1995, 74:584-591.
5. Arca M., Pannitteri G., Campagna F., et al. Angiotensin-converting enzyme gene polymorphism is not associated with coronary atherosclerosis and myocardial infarction in a sample of Italian patients. Eur. J. Clin. Invest. 1998, 28:485-490.
6. Attia J., Thakkinstian A., D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J. Clin. Epidemiol. 2003, 56:297-303.
7. Batalla A., Alvarez R., Reguero J.R., et al. Synergistic effect between apolipoprotein E and angiotensinogen gene polymorphisms in the risk for early myocardial infarction. Clin. Chem. 2000, 46:1910-1915.
8. Baudin B. Angiotensin I-converting enzyme gene polymorphism and drug response. Clin. Chem. Lab. Med. 2000, 38:853-856.
9. Bautista L.E., Ardila M.E., Gamarra G., Vargas C.I., Arenas I.A. Angiotensin-converting enzyme gene polymorphism and risk of myocardial infarction in Colombia. Med. Sci. Monit. 2004, 10:CR473-CR479.
10. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
11. Bohn M., Berge K.E., Bakken A., Erikssen J., Berg K. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin. Genet. 1993, 44:292-297.
12. Cambien F. The angiotensin-converting enzyme (ACE) genetic polymorphism: its relationship with plasma ACE level and myocardial infarction. Clin. Genet. 1994, 46:94-101.
13. Cambien F., Poirier O., Lecerf L., et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992, 359:641-644.
14. Canavy I., Henry M., Morange P.E., et al. Genetic polymorphisms and coronary artery disease in the south of France. Thromb. Haemost. 2000, 83:212-216.
15. Cheitlin M.D. Cardiovascular physiology-changes with aging. Am. J. Geriatr. Cardiol. 2003, 12:9-13.
16. Chen L., Liu L., Hong K., Hu J., Cheng X. Three genetic polymorphisms of homocysteine-metabolizing enzymes and risk of coronary heart disease: a meta-analysis based on 23 case-control studies. DNA Cell Biol. 2012, 31:238-249.
17. Das S.R., Alexander K.P., Chen A.Y., et al. Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry). J. Am. Coll. Cardiol. 2011, 58:2642-2650.
18. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:177-188.
19. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
20. Engel L.S., Taioli E., Pfeiffer R., et al. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am. J. Epidemiol. 2002, 156:95-109.
21. Ermis C., Tsai M.Y., Hanson N.Q., Akar N., Aras O. Angiotensin I converting enzyme, angiotensin II type 1 receptor and angiotensinogen polymorphisms and early myocardial infarction in Turkish population. Thromb. Haemost. 2002, 88:693-694.
22. Fernandez-Arcas N., Dieguez-Lucena J.L., Munoz-Moran E., et al. The genotype interactions of methylenetetrahydrofolate reductase and renin-angiotensin system genes are associated with myocardial infarction. Atherosclerosis 1999, 145:293-300.
23. Fomicheva E.V., Gukova S.P., Larionova-Vasina V.I., Kovalev Y.R., Schwartz E.I. Gene-gene interaction in the RAS system in the predisposition to myocardial infarction in elder population of St. Petersburg (Russia). Mol. Genet. Metab. 2000, 69:76-80.
24. Franco E., Palumbo L., Crobu F., et al. Renin-angiotensin-aldosterone system polymorphisms: a role or a hole in occurrence and long-term prognosis of acute myocardial infarction at young age. BMC Med. Genet. 2007, 8:27.
25. Fujisawa T., Ikegami H., Shen G.Q., et al. Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 1995, 18:983-985.
26. Gao J., Shao Y., Lai W., Ren H., Xu D. Association of polymorphisms in the RAGE gene with serum CRP levels and coronary artery disease in the Chinese Han population. J. Hum. Genet. 2010, 55:668-675.
27. Gardemann A., Nguyen Q.D., Humme J., et al. Angiotensin II type 1 receptor A1166C gene polymorphism. Absence of an association with the risk of coronary artery disease and myocardial infarction and of a synergistic effect with angiotensin-converting enzyme gene polymorphism on the risk of these diseases. Eur. Heart J. 1998, 19:1657-1665.
28. Gerber Y., Rosen L.J., Goldbourt U., Benyamini Y., Drory Y. Smoking status and long-term survival after first acute myocardial infarction: a population-based cohort study. J. Am. Coll. Cardiol. 2009, 54:2382-2387.
29. Hamelin B.A., Zakrzewski-Jakubiak M., Robitaille N.M., et al. Increased risk of myocardial infarction associated with angiotensin-converting enzyme gene polymorphism is age dependent. J. Clin. Pharmacol. 2011, 51:1286-1292.
30. Hooper W.C., Dowling N.F., Wenger N.K., et al. Relationship of venous thromboembolism and myocardial infarction with the renin-angiotensin system in African-Americans. Am. J. Hematol. 2002, 70:1-8.
31. Hubacek J.A., Pitha J., Podrapska I., et al. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene in myocardial infarction survivors. Med. Sci. Monit. 2000, 6:503-506.
32. Karayannis G., Tsezou A., Giannatou E., et al. Polymorphisms of renin-angiotensin system and natriuretic peptide receptor A genes in patients of Greek origin with a history of myocardial infarction. Angiology 2010, 61:737-743.
33. Keavney B., McKenzie C., Parish S., et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet 2000, 355:434-442.
34. Kee F., Morrison C., Poirier O., et al. Angiotensin II type-I receptor and ACE polymorphisms and risk of myocardial infarction in men and women. Eur. J. Clin. Invest. 2000, 30:1076-1082.
35. Kuznetsova T., Staessen J.A., Wang J.G., et al. Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: a meta-analysis. J. Hum. Hypertens. 2000, 14:447-454.
36. Li Y., Guo J., Chen D., et al. Association study of angiotensin converting enzyme polymorphism with myocardial infarction in Chinese. J. Beijing Med. Univ. 1999, 31:540-542.
37. Lindpaintner K., Pfeffer M.A., Kreutz R., et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N. Engl. J. Med. 1995, 332:706-711.
38. Liu L., Zeng F., Wang K., et al. Meta-analysis of the association between VEGF-634 G>C and risk of malignancy based on 23 case-control studies. J. Cancer Res. Clin. Oncol. 2011, 137:1027-1036.
39. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22:719-748.
40. Marques-Vidal P., Bongard V., Ruidavets J.B., et al. Effect of apolipoprotein E alleles and angiotensin-converting enzyme insertion/deletion polymorphisms on lipid and lipoprotein markers in middle-aged men and in patients with stable angina pectoris or healed myocardial infarction. Am. J. Cardiol. 2003, 92:1102-1105.
41. Mehri S., Baudin B., Mahjoub S., et al. Angiotensin-converting enzyme insertion/deletion gene polymorphism in a Tunisian healthy and acute myocardial infarction population. Genet. Test. Mol. Biomarkers 2010, 14:85-91.
42. Murphey L.J., Gainer J.V., Vaughan D.E., Brown N.J. Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. Circulation 2000, 102:829-832.
43. Naber C.K., Husing J., Wolfhard U., Erbel R., Siffert W. Interaction of the ACE D allele and the GNB3 825T allele in myocardial infarction. Hypertension 2000, 36:986-989.
44. Nakai K., Fusazaki T., Zhang T., et al. Polymorphism of the apolipoprotein E and angiotensin I converting enzyme genes in Japanese patients with myocardial infarction. Coron. Artery Dis. 1998, 9:329-334.
45. Pfohl M., Koch M., Prescod S., et al. Angiotensin I-converting enzyme gene polymorphism, coronary artery disease and myocardial infarction. An angiographically controlled study. Eur. Heart J. 1999, 20:1318-1325.
46. Pulla Reddy B., Srikanth Babu B.M., Venkata Karunakar K., et al. Angiotensin-converting enzyme gene variant and its levels: risk factors for myocardial infarction in a South Indian population. Singapore Med. J. 2010, 51:576-581.
47. Rallidis L.S., Gialeraki A., Varounis C., et al. Lack of association of angiotensin-converting enzyme insertion/deletion polymorphism and myocardial infarction at very young ages. Biomarkers 2009, 14:401-405.
48. Ranjith N., Pegoraro R.J., Rom L., Lanning P.A., Naidoo D.P. Renin-angiotensin system and associated gene polymorphisms in myocardial infarction in young South African Indians. Cardiovasc. J. S. Afr. 2004, 15:22-26.
49. Ruiz J., Blanche H., Cohen N., et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:3662-3665.
50. Samani N.J., O'Toole L., Martin D., et al. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction. J. Am. Coll. Cardiol. 1996, 28:338-344.
51. Samani N.J., Thompson J.R., O'Toole L., Channer K., Woods K.L. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996, 94:708-712.
52. Schuster H., Wienker T.F., Stremmler U., et al. An angiotensin-converting enzyme gene variant is associated with acute myocardial infarction in women but not in men. Am. J. Cardiol. 1995, 76:601-603.
53. Seckin D., Ilhan N., Ozbay Y. The relationship between ACE insertion/deletion polymorphism and coronary artery disease with or without myocardial infarction. Clin. Biochem. 2006, 39:50-54.
54. Settin A., Elbaz R., Abbas A., Abd-Al-Samad A., Noaman A. Angiotensin-converting enzyme gene insertion/deletion polymorphism in Egyptian patients with myocardial infarction. J. Renin Angiotensin Aldosterone Syst. 2009, 10:96-100.
55. Staessen J.A., Wang J.G., Ginocchio G., et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J. Hypertens. 1997, 15:1579-1592.
56. Sun L., Hu W., Yang J., et al. Association of the angiotensin converting enzyme I/D polymorphism and angiotensinogen T174M gene polymorphism with acute myocardial infarction. Chin. J. Atheroscler. 2006, 14:697-700.
57. Touyz R.M., Schiffrin E.L. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol. Rev. 2000, 52:639-672.
58. Turner E.H., Matthews A.M., Linardatos E., Tell R.A., Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N. Engl. J. Med. 2008, 358:252-260.
59. Yang Y., Zhang F., Ding R., et al. Association of ADIPOQ gene polymorphisms and coronary artery disease risk: A meta-analysis based on 12 465 subjects. Thromb. Res. 2012, 130:58-64.
60. Zhang Y., Zhou S., Zhao X., Lei J. Relationship between polymorphism of angiotensin I converting enzyme gene insertion/deletion and ACE, PAI-1 activity in patients with myocardial infarction. Chin. J. Pathophysiol. 2006, 22:2336-2339.
61. Zhao J., Qu X., Miao R., Wang H., Huang Y. Relationship between angiotensin-1 converting enzyme gene polymorphism and acute myocardial infarction. Chin. J. Crit. Care Med. 2000, 22:444-446.
62. Zhou L., Xi B., Wei Y., Shen W., Li Y. Meta-analysis of the association between the insertion/deletion polymorphism in ACE gene and coronary heart disease among the Chinese population. J. Renin. Angiotensin Aldosterone Syst. 2012, 13:296-304.
63. Zintzaras E., Raman G., Kitsios G., Lau J. Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch. Intern. Med. 2008, 168:1077-1089.